Cargando…

Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm

BACKGROUND: In resource-limited settings, where resistance testing is unavailable, confirmatory testing for patients with high viral loads (VL) delays antiretroviral therapy (ART) switches for persons with resistance. We developed a risk score algorithm to predict need for ART change by identifying...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rutstein, Sarah E., Hosseinipour, Mina C., Weinberger, Morris, Wheeler, Stephanie B., Biddle, Andrea K., Wallis, Carole L., Balakrishnan, Pachamuthu, Mellors, John W., Morgado, Mariza, Saravanan, Shanmugam, Tripathy, Srikanth, Vardhanabhuti, Saran, Eron, Joseph J., Miller, William C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906700/ https://www.ncbi.nlm.nih.gov/pubmed/27296625 http://dx.doi.org/10.1186/s12879-016-1611-2

Ejemplares similares

Differentiated Care Pathways for Antiretroviral Therapy Monitoring in Malawi: Expanding Viral Load Testing in Setting of Highly Prevalent Resistance
por: Rutstein, Sarah E, et al.
Publicado: (2017)

Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230
por: Vardhanabhuti, Saran, et al.
Publicado: (2016)

Dried Blood Spots for Viral Load Monitoring in Malawi: Feasible and Effective
por: Rutstein, Sarah E., et al.
Publicado: (2015)

Randomized Controlled Pilot Study of Antiretrovirals and a Behavioral Intervention for Persons With Acute HIV Infection: Opportunity for Interrupting Transmission
por: Miller, William C, et al.
Publicado: (2018)

The Implementation of HIV Self-Testing in Resource-Limited Settings Where the HIV Disease Burden is High
por: Balakrishnan, Pachamuthu, et al.
Publicado: (2023)

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa
por: Wallis, Carole L., et al.
Publicado: (2011)

Correlates of HIV and malaria co-infection in Southern India
por: Bharti, Ajay R, et al.
Publicado: (2012)

Expression of the human microRNA miR 29a in an Indian cohort of HIV patients
por: Dey, Rakesh, et al.
Publicado: (2014)

High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up
por: Rutstein, Sarah E., et al.
Publicado: (2019)

Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?
por: Shankar, Esaki Muthu, et al.
Publicado: (2008)

Longer sequence insertions in p6 gag play a role in immune escape in HIV-1 subtype C
por: Sharma, Shilpee, et al.
Publicado: (2014)

Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients
por: Subashini, Dhakshinamoorthy, et al.
Publicado: (2016)

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa
por: Sharma, Shilpee, et al.
Publicado: (2017)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

Anti-HIV microRNA expression in a novel Indian cohort
por: Dey, Rakesh, et al.
Publicado: (2016)

The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment
por: Skinner-Adams, Tina S., et al.
Publicado: (2012)

Position and distance specificity are important determinants of cis-regulatory motifs in addition to evolutionary conservation
por: Vardhanabhuti, Saran, et al.
Publicado: (2007)

Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study
por: Rutstein, Sarah E., et al.
Publicado: (2022)

108. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
por: Gandhi, Rajesh, et al.
Publicado: (2020)

Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India
por: Solomon, Sunil S., et al.
Publicado: (2016)

Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
por: Gandhi, Rajesh T., et al.
Publicado: (2017)

Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi
por: Feldacker, Caryl, et al.
Publicado: (2012)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
por: Sinha, Sanjeev, et al.
Publicado: (2017)

Comparative sensitivity of automated (Abbott M2000) and manual plasma HIV-1 RNA PCR assays for the detection of persistent viremia after long-term antiretroviral therapy
por: Tosiano, Melissa A., et al.
Publicado: (2022)

Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
por: Salata, Robert A., et al.
Publicado: (2023)

Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients
por: Subashini, Dhakshinamoorthy, et al.
Publicado: (2018)

Low-cost assays for monitoring HIV infected individuals in resource-limited settings
por: Balakrishnan, Pachamuthu, et al.
Publicado: (2011)

Frequent cross-resistance to rilpivirine among subtype C HIV-1 from first-line antiretroviral therapy failures in South Africa
por: Penrose, Kerri J, et al.
Publicado: (2018)

Patterns of Contraceptive Adoption, Continuation, and Switching after Delivery among Malawian Women
por: Kopp, Dawn M., et al.
Publicado: (2017)

Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy
por: Li, Jonathan Z., et al.
Publicado: (2014)

Malnutrition: Modulator of Immune Responses in Tuberculosis
por: Chandrasekaran, Padmapriyadarsini, et al.
Publicado: (2017)

Application of mobile phone technology as intervention for the management of tuberculosis patients diagnosed through community survey
por: Selvaraju, Sriram, et al.
Publicado: (2022)

Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women
por: Chagomerana, Maganizo B., et al.
Publicado: (2018)

A prospective analysis of viral immune escape in the chronic phase of the subtype C HIV-1 infections of India
por: Sharma, Shilpee, et al.
Publicado: (2012)

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
por: Balagopal, Ashwin, et al.
Publicado: (2016)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
por: Mahomed, Kairoonisha, et al.
Publicado: (2020)

284. Antibiotic Usage in the First Year of Life in HIV-Exposed, Uninfected Infants in Malawi: Results From the Breastfeeding, Antiretrovirals and Nutrition (BAN) Study
por: Kourtis, Athena, et al.
Publicado: (2018)

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
por: Campbell, Thomas B., et al.
Publicado: (2012)

Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings
por: Abbas, Ume L., et al.
Publicado: (2007)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fdlfsds4gpojg7grjilb6irmjn